Miki Hori
Primary Podiatric Medicine · Harrisonburg, VANPI 1316949068
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (36.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Arthrex at 45.3% of the total. Reporting peaked in 2022 at $4,655 and has fallen 94.5% since, to $256 in 2025.
Across 68 payments — averaging $97.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Stryker$2K
- Treace Medical Concepts, Inc.$742
- Fortis Surgical, LLC$639
- Smith+Nephew$194
- Bioventus LLC$55
- plus $138 from 7 others
What the payments were for
- Travel & lodging$2,30635%
- Food & beverage$1,91429%
- Education$2,40036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 15 | $2,996 |
| Stryker | 24 | $1,855 |
| Treace Medical Concepts, Inc. | 5 | $742 |
| Fortis Surgical, LLC | 5 | $639 |
| Smith+Nephew | 9 | $194 |
| Bioventus LLC | 3 | $55 |
| Johnson & Johnson | 1 | $45 |
| KCI USA, Inc. | 1 | $32 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Integra Lifesciences Corporation | 1 | $13 |
| Arthrosurface Incorporated | 1 | $11 |
| Organogenesis Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$807
- Lapiplasty System$684
- BIOLOX$142
- AUGMENT INJECTABLE$129
How this compares
Too few primary podiatric medicine providers in Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 70 | $613 |
| Cephalexin | 63 | $357 |
| Doxycycline Hyclate | 17 | $195 |
| Clindamycin Hcl | 16 | $138 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $72 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Harrisonburg
- Edward PozarnyArlington$2K
- Thomas DavidsonRoanoke$2K
- Anne ShafferGainesville$196
- Mukesh BhaktaGainesville$132
- Rodney KanderLovettsville$105
- Samuel PersonPetersburg$95
- Robert BreinerAnnandale$50
- Bruce FreedmanRichlands$15
- Toni ChadwickSalem$7
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.